Requirement of different signaling pathways mediated by insulin-like growth factor-I receptor for proliferation, invasion, and VPF/VEGF expression in a pancreatic carcinoma cell line.

[1]  D. Hanahan,et al.  Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis. , 2002, Cancer cell.

[2]  D. Mukhopadhyay,et al.  Vascular Permeability Factor (VPF)/Vascular Endothelial Growth Factor (VEGF) Receptor-1 Down-modulates VPF/VEGF Receptor-2-mediated Endothelial Cell Proliferation, but Not Migration, through Phosphatidylinositol 3-Kinase-dependent Pathways* , 2001, The Journal of Biological Chemistry.

[3]  J. Testa,et al.  AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. , 2001, Cancer research.

[4]  S. Nakazawa,et al.  The Autocrine Loop of Epidermal Growth Factor Receptor‐Epidermal Growth Factor/Transforming Growth Factor‐α in Malignant Rhabdoid Tumor Cell Lines: Heterogeneity of Autocrine Mechanism in TTC549 , 2001, Japanese journal of cancer research : Gann.

[5]  K. Matsumoto,et al.  NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells , 2001, British Journal of Cancer.

[6]  D. Mukhopadhyay,et al.  Role of Protein Kinase Cζ in Ras-mediated Transcriptional Activation of Vascular Permeability Factor/Vascular Endothelial Growth Factor Expression* , 2001, The Journal of Biological Chemistry.

[7]  J. Han,et al.  Overexpression of c‐H‐ras p21 is correlated with vascular endothelial growth factor expression and neovascularization in advanced gastric carcinoma 1 , 2000, Journal of gastroenterology and hepatology.

[8]  D. O’Rourke,et al.  Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and distinct from that induced by hypoxia. , 2000, Cancer research.

[9]  C. Balabaud,et al.  Hepatocarcinoma cells stimulate hepatocyte growth factor secretion in human liver myofibroblasts. , 2000, International journal of oncology.

[10]  Shigeyoshi Itohara,et al.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.

[11]  G. Adler,et al.  TGFβ1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation , 2000, Oncogene.

[12]  D. Coppola,et al.  Molecular prognostic markers in pancreatic cancer. , 2000, Cancer control : journal of the Moffitt Cancer Center.

[13]  O. Volpert,et al.  Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Mukhopadhyay,et al.  Inhibition of Insulin-like Growth Factor-I-mediated Cell Signaling by the von Hippel-Lindau Gene Product in Renal Cancer* , 2000, The Journal of Biological Chemistry.

[15]  D. Vordermark,et al.  Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells. , 2000, Anticancer research.

[16]  Peter Gierschik,et al.  Growth factor-dependent activation of the Ras-Raf-MEK-MAPK pathway in the human pancreatic carcinoma cell line PANC-1 carrying activated K-ras: implications for cell proliferation and cell migration , 2000, Oncogene.

[17]  S. Tóth,et al.  Autocrine and paracrine regulation by cytokines and growth factors in melanoma. , 2000, Cytokine.

[18]  T. Fukuda,et al.  High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma , 2000, Cancer.

[19]  K. Konishi,et al.  Evaluation of PCNA, p53, K-ras and LOH in endocrine pancreas tumors. , 2000, Hepato-gastroenterology.

[20]  C. Ulrich.  Growth factors, receptors, and molecular alterations in pancreatic cancer. Putting it all together. , 2000, The Medical clinics of North America.

[21]  A. Çoker,et al.  Angiogenesis and p53 and H-ras mutations in pancreatic ductal adenocarcinoma. , 1999, Analytical and quantitative cytology and histology.

[22]  R. A. Lacalle,et al.  Insulin-Like Growth Factor I-Triggered Cell Migration and Invasion Are Mediated by Matrix Metalloproteinase-9. , 1999, Endocrinology.

[23]  S. Leung,et al.  Tissue-specific expression pattern of vascular endothelial growth factor isoforms in the malignant transformation of lung and colon. , 1998, Human pathology.

[24]  A. Hoeflich,et al.  Src Stimulates Insulin-like Growth Factor I (igf-i)-dependent Cell Proliferation by Increasing Igf-i Receptor Number in Human Pancreatic Carcinoma Cells1 Overexpression of Kinase-activated Srcy527f Resulted in a Signif Icant Increase of Insulin-like Growth Factor I (igf-i)-dependent Cell pro Liferat , 2022 .

[25]  Sandra,et al.  A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. , 1998, Cancer research.

[26]  P. Brodt,et al.  Enhanced invasion and liver colonization by lung carcinoma cells overexpressing the type 1 insulin-like growth factor receptor. , 1998, Experimental cell research.

[27]  L. Ellis,et al.  Down-regulation of Vascular Endothelial Growth Factor in a Human Colon Carcinoma Cell Line Transfected with an Antisense Expression Vector Specific for c-src * , 1998, The Journal of Biological Chemistry.

[28]  P. V. van Diest,et al.  Expression of growth factors, growth‐inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis , 1998, The Journal of pathology.

[29]  T. Pawson,et al.  Signaling through scaffold, anchoring, and adaptor proteins. , 1997, Science.

[30]  G. Semenza,et al.  V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. , 1997, Cancer research.

[31]  S. Mandriota,et al.  Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. , 1997, Journal of cell science.

[32]  M. Rubini,et al.  The IGF-I receptor in cell growth, transformation and apoptosis. , 1997, Biochimica et biophysica acta.

[33]  C. Cetrulo,et al.  Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals. , 1997, Journal of molecular and cellular cardiology.

[34]  D. Mukhopadhyay,et al.  Depletion of [Ca2+]i inhibits hypoxia-induced vascular permeability factor (vascular endothelial growth factor) gene expression. , 1996, Biochemical and biophysical research communications.

[35]  M. Asaka,et al.  An effect of K‐ras gene mutation on epidermal growth factor receptor signal transduction in PANC‐1 pancreatic carcinoma cells , 1996, International journal of cancer.

[36]  M. Detmar,et al.  Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. , 1996, The American journal of pathology.

[37]  L. E. Stevenson,et al.  Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the RAS signaling pathway , 1996, International journal of cancer.

[38]  K. Plate,et al.  Angiogenesis in malignant gliomas , 1995, Glia.

[39]  G. Viglietto,et al.  Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines. , 1995, Oncogene.

[40]  D. Mukhopadhyay,et al.  Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation , 1995, Nature.

[41]  M. Korc,et al.  Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. , 1995, Cancer research.

[42]  G. D. Phillips,et al.  Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogenesis in the rabbit cornea. , 1994, In vivo.

[43]  M. Shibuya,et al.  Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. , 1994, The Journal of biological chemistry.

[44]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[45]  P. Hall,et al.  Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. , 1991, British Journal of Cancer.

[46]  R. Eddy,et al.  Identification of a new endothelial cell growth factor receptor tyrosine kinase. , 1991, Oncogene.

[47]  D. Connolly,et al.  Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration , 1990, The Journal of experimental medicine.

[48]  D. Goeddel,et al.  Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.

[49]  D. Connolly,et al.  Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. , 1989, The Journal of clinical investigation.

[50]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.

[51]  J. J. Abel,et al.  ON THE DECOMPOSITION PRODUCTS OF EPINEPHRIN HYDRATE , 1905 .

[52]  H. Friess,et al.  Growth factors and their receptors in pancreatic cancer. , 2001, Teratogenesis, carcinogenesis, and mutagenesis.

[53]  J. Ringel,et al.  Transforming Growth Factor-β1 Induces Desmoplasia in an Experimental Model of Human Pancreatic Carcinoma , 2001 .

[54]  S. Dunn.  Insulin-like growth factor I stimulate angiogenesis and the production of vascular endothelial growth factor , 2000 .

[55]  H. Kijima,et al.  Ribozyme as an approach for growth suppression of human pancreatic cancer , 2000, Molecular biotechnology.

[56]  M. Korc,et al.  Concomitant over‐expression of vascular endothelial growth factor and its receptors in pancreatic cancer , 2000, International journal of cancer.

[57]  P. Dell’Era,et al.  Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. , 2000, Advances in experimental medicine and biology.

[58]  T. Gress,et al.  Invasion and metastasis in pancreatic cancer. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[59]  R. Tomaszewska.  [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma]. , 1999, Folia medica Cracoviensia.